De-repressing LncRNA-targeted genes to upregulate gene expression: Focus on small molecule therapeutics

Molecular Therapy Nucleic Acids

Volumn 3, Issue , 2014, Pages e196-

  Fatemi, Roya Pedram ^a   Velmeshev, Dmitry ^a   Faghihi, Mohammad Ali ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Cardiovascular disease; Epigenetics; Gene upregulation; Long intervening RNAs; Long noncoding RNA; Natural antisense transcript; Neurological disorders; Protein RNA interactions; RNA structure

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; LONG UNTRANSLATED RNA; VIRUS VECTOR;

AUTOIMMUNE DISEASE; BECKWITH WIEDEMANN SYNDROME; BILE DUCT CARCINOMA; CARDIOVASCULAR DISEASE; DEGENERATIVE DISEASE; DRUG TARGETING; EPIGENETIC REPRESSION; GENE EXPRESSION; GENE TARGETING; LEUKEMIA; NEOPLASM; NEUROBLASTOMA; NEUROPROTECTION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN RNA BINDING; REVIEW; TRANSCRIPTOMICS; TUMOR SUPPRESSOR GENE; UPREGULATION;

EID: 84925235630     PISSN: None     EISSN: 21622531     Source Type: Journal    
DOI: 10.1038/mtna.2014.45     Document Type: Review

References (136)

1. Birney, E, Stamatoyannopoulos, JA, Dutta, A, Guigó, R, Gingeras, TR, Margulies, EH et al. (2007). Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447: 799-816.
2. Katayama, S, Tomaru, Y, Kasukawa, T, Waki, K, Nakanishi, M, Nakamura, M et al.; RIKEN Genome Exploration Research Group; Genome Science Group (Genome Network Project Core Group); FANTOM Consortium. (2005). Antisense transcription in the mammalian transcriptome. Science 309: 1564-1566.
3. Carninci, P, Kasukawa, T, Katayama, S, Gough, J, Frith, MC, Maeda, N et al.; FANTOM Consortium; RIKEN Genome Exploration Research Group and Genome Science Group (Genome Network Project Core Group). (2005). The transcriptional landscape of the mammalian genome. Science 309: 1559-1563.
4. Bernstein, BE, Birney, E, Dunham, I, Green, ED, Gunter, C, Snyder, M et al. (2012). An integrated encyclopedia of DNA elements in the human genome. Nature 489: 57-74.
5. Djebali, S, Davis, CA, Merkel, A, Dobin, A, Lassmann, T, Mortazavi, A et al. (2012). Landscape of transcription in human cells. Nature 489: 101-108.
6. Derrien, T, Johnson, R, Bussotti, G, Tanzer, A, Djebali, S, Tilgner, H et al. (2012). The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res 22: 1775-1789.
7. Kapranov, P, Cheng, J, Dike, S, Nix, DA, Duttagupta, R, Willingham, AT et al. (2007). RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science 316: 1484-1488.
8. Denoeud, F, Kapranov, P, Ucla, C, Frankish, A, Castelo, R, Drenkow, J et al. (2007). Prominent use of distal 5' transcription start sites and discovery of a large number of additional exons in ENCODE regions. Genome Res 17: 746-759.
9. Findeiss, S, Schmidtke, C, Stadler, PF and Bonas, U (2010). A novel family of plasmid-transferred anti-sense ncRNAs. RNA Biol 7: 120-124.
10. Venter, JC, Adams, MD, Myers, EW, Li, PW, Mural, RJ, Sutton, GG et al. (2001). The sequence of the human genome. Science 291: 1304-1351.
11. Lander, ES, Linton, LM, Birren, B, Nusbaum, C, Zody, MC, Baldwin, J et al.; International Human Genome Sequencing Consortium. (2001). Initial sequencing and analysis of the human genome. Nature 409: 860-921.
12. Collins, FS, Lander, ES, Rogers, J, Waterston, RH; The International Human Genome Sequencing Consortium. (2004). Finishing the euchromatic sequence of the human genome. Nature 431: 931-945.
13. Mattick, JS (2004). RNA regulation: a new genetics? Nat Rev Genet 5: 316-323.
14. Kapranov, P, St Laurent, G, Raz, T, Ozsolak, F, Reynolds, CP, Sorensen, PH et al. (2010). The majority of total nuclear-encoded non-ribosomal RNA in a human cell is 'dark matter' un-annotated RNA. BMC Biol 8: 149.
15. Ambros, V (2001). microRNAs: tiny regulators with great potential. Cell 107: 823-826.
16. Elbashir, SM, Harborth, J, Lendeckel, W, Yalcin, A, Weber, K and Tuschl, T (2001). Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411: 494-498.
17. Caplen, NJ, Parrish, S, Imani, F, Fire, A and Morgan, RA (2001). Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc Natl Acad Sci USA 98: 9742-9747.
18. Lee, RC and Ambros, V (2001). An extensive class of small RNAs in Caenorhabditis elegans. Science 294: 862-864.
19. Lau, NC, Lim, LP, Weinstein, EG and Bartel, DP (2001). An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 294: 858-862.
20. Lagos-Quintana, M, Rauhut, R, Lendeckel, W and Tuschl, T (2001). Identification of novel genes coding for small expressed RNAs. Science 294: 853-858.
21. Zhang, B, Arun, G, Mao, YS, Lazar, Z, Hung, G, Bhattacharjee, G et al. (2012). The lncRNA Malat1 is dispensable for mouse development but its transcription plays a cis-regulatory role in the adult. Cell Rep 2: 111-123.
22. Li, L, Liu, B, Wapinski, OL, Tsai, MC, Qu, K, Zhang, J et al. (2013). Targeted disruption of Hotair leads to homeotic transformation and gene derepression. Cell Rep 5: 3-12.
23. Sauvageau, M, Goff, LA, Lodato, S, Bonev, B, Groff, AF, Gerhardinger, C et al. (2013). Multiple knockout mouse models reveal lincRNAs are required for life and brain development. Elife 2: e01749.
24. Tripathi, V, Ellis, JD, Shen, Z, Song, DY, Pan, Q, Watt, AT et al. (2010). The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol Cell 39: 925-938.
25. Bernard, D, Prasanth, KV, Tripathi, V, Colasse, S, Nakamura, T, Xuan, Z et al. (2010). A long nuclear-retained non-coding RNA regulates synaptogenesis by modulating gene expression. EMBO J 29: 3082-3093.
26. Nakagawa, S, Ip, JY, Shioi, G, Tripathi, V, Zong, X, Hirose, T et al. (2012). Malat1 is not an essential component of nuclear speckles in mice. RNA 18: 1487-1499.
27. Eissmann, M, Gutschner, T, Hämmerle, M, Günther, S, Caudron-Herger, M, Groß, M et al. (2012). Loss of the abundant nuclear non-coding RNA MALAT1 is compatible with life and development. RNA Biol 9: 1076-1087.
28. Kino, T, Hurt, DE, Ichijo, T, Nader, N and Chrousos, GP (2010). Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci Signal 3: ra8.
29. Pickard, MR, Mourtada-Maarabouni, M and Williams, GT (2013). Long non-coding RNA GAS5 regulates apoptosis in prostate cancer cell lines. Biochim Biophys Acta 1832: 1613-1623.
30. Faghihi, MA, Zhang, M, Huang, J, Modarresi, F, Van der Brug, MP, Nalls, MA et al. (2010). Evidence for natural antisense transcript-mediated inhibition of microRNA function. Genome Biol 11: R56.
31. Faghihi, MA, Modarresi, F, Khalil, AM, Wood, DE, Sahagan, BG, Morgan, TE et al. (2008). Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feedforward regulation of beta-secretase. Nat Med 14: 723-730.
32. Andersson, R, Gebhard, C, Miguel-Escalada, I, Hoof, I, Bornholdt, J, Boyd, M et al.; FANTOM Consortium. (2014). An atlas of active enhancers across human cell types and tissues. Nature 507: 455-461.
33. Ørom, UA, Derrien, T, Beringer, M, Gumireddy, K, Gardini, A, Bussotti, G et al. (2010). Long noncoding RNAs with enhancer-like function in human cells. Cell 143: 46-58.
34. Guttman, M, Donaghey, J, Carey, BW, Garber, M, Grenier, JK, Munson, G et al. (2011). lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature 477: 295-300.
35. Tsai, MC, Manor, O, Wan, Y, Mosammaparast, N, Wang, JK, Lan, F et al. (2010). Long noncoding RNA as modular scaffold of histone modification complexes. Science 329: 689-693.
36. Huarte, M, Guttman, M, Feldser, D, Garber, M, Koziol, MJ, Kenzelmann-Broz, D et al. (2010). A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 142: 409-419.
37. Khalil, AM, Guttman, M, Huarte, M, Garber, M, Raj, A, Rivea Morales, D et al. (2009). Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci USA 106: 11667-11672.
38. Modarresi, F, Faghihi, MA, Lopez-Toledano, MA, Fatemi, RP, Magistri, M, Brothers, SP et al. (2012). Inhibition of natural antisense transcripts in vivo results in gene-specific transcriptional upregulation. Nat Biotechnol 30: 453-459.
39. Rinn, JL, Kertesz, M, Wang, JK, Squazzo, SL, Xu, X, Brugmann, SA et al. (2007). Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129: 1311-1323.
40. Brown, CJ, Hendrich, BD, Rupert, JL, Lafrenière, RG, Xing, Y, Lawrence, J et al. (1992). The human XIST gene: analysis of a 17 kb inactive X-specific RNA that contains conserved repeats and is highly localized within the nucleus. Cell 71: 527-542.
41. Zhao, J, Sun, BK, Erwin, JA, Song, JJ and Lee, JT (2008). Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome. Science 322: 750-756.
42. Mohammad, F, Mondal, T, Guseva, N, Pandey, GK and Kanduri, C (2010). Kcnq1ot1 noncoding RNA mediates transcriptional gene silencing by interacting with Dnmt1. Development 137: 2493-2499.
43. Pandey, RR, Mondal, T, Mohammad, F, Enroth, S, Redrup, L, Komorowski, J et al. (2008). Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation. Mol Cell 32: 232-246.
44. Mohammad, F, Pandey, RR, Nagano, T, Chakalova, L, Mondal, T, Fraser, P et al. (2008). Kcnq1ot1/Lit1 noncoding RNA mediates transcriptional silencing by targeting to the perinucleolar region. Mol Cell Biol 28: 3713-3728.
45. Sleutels, F, Zwart, R and Barlow, DP (2002). The non-coding Air RNA is required for silencing autosomal imprinted genes. Nature 415: 810-813.
46. Nagano, T, Mitchell, JA, Sanz, LA, Pauler, FM, Ferguson-Smith, AC, Feil, R et al. (2008). The Air noncoding RNA epigenetically silences transcription by targeting G9a to chromatin. Science 322: 1717-1720.
47. Mercer, TR, Dinger, ME, Sunkin, SM, Mehler, MF and Mattick, JS (2008). Specific expression of long noncoding RNAs in the mouse brain. Proc Natl Acad Sci USA 105: 716-721.
48. Necsulea, A, Soumillon, M, Warnefors, M, Liechti, A, Daish, T, Zeller, U et al. (2014). The evolution of lncRNA repertoires and expression patterns in tetrapods. Nature 505: 635-640.
49. Ramos, AD, Diaz, A, Nellore, A, Delgado, RN, Park, KY, Gonzales-Roybal, G et al. (2013). Integration of genome-wide approaches identifies lncRNAs of adult neural stem cells and their progeny in vivo. Cell Stem Cell 12: 616-628.
50. Pollard, KS, Salama, SR, Lambert, N, Lambot, MA, Coppens, S, Pedersen, JS et al. (2006). An RNA gene expressed during cortical development evolved rapidly in humans. Nature 443: 167-172.
51. Forrest, AR, Kawaji, H, Rehli, M, Baillie, JK; The FANTOM Consortium and the RIKEN PMI and CLST (DGT), et al. (2014). A promoter-level mammalian expression atlas. Nature 507: 462-470.
52. Schug, J, Schuller, WP, Kappen, C, Salbaum, JM, Bucan, M and Stoeckert, CJ Jr (2005). Promoter features related to tissue specificity as measured by Shannon entropy. Genome Biol 6: R33.
53. Yap, KL, Li, S, Muñoz-Cabello, AM, Raguz, S, Zeng, L, Mujtaba, S et al. (2010). Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell 38: 662-674.
54. Rinn, JL and Chang, HY (2012). Genome regulation by long noncoding RNAs. Annu Rev Biochem 81: 145-166.
55. Sopher, BL, Ladd, PD, Pineda, VV, Libby, RT, Sunkin, SM, Hurley, JB et al. (2011). CTCF regulates ataxin-7 expression through promotion of a convergently transcribed, antisense noncoding RNA. Neuron 70: 1071-1084.
56. Gupta, RA, Shah, N, Wang, KC, Kim, J, Horlings, HM, Wong, DJ et al. (2010). Long noncoding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464: 1071-1076.
57. Sørensen, KP, Thomassen, M, Tan, Q, Bak, M, Cold, S, Burton, M et al. (2013). Long non-coding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptor-positive primary breast cancer. Breast Cancer Res Treat 142: 529-536.
58. Tang, L, Zhang, W, Su, B and Yu, B (2013). Long noncoding RNA HOTAIR is associated with motility, invasion, and metastatic potential of metastatic melanoma. Biomed Res Int 2013: 251098.
59. Chen, FJ, Sun, M, Li, SQ, Wu, QQ, Ji, L, Liu, ZL et al. (2013). Upregulation of the long noncoding RNA HOTAIR promotes esophageal squamous cell carcinoma metastasis and poor prognosis. Mol Carcinog 52: 908-915.
60. Hajjari, M, Behmanesh, M, Sadeghizadeh, M and Zeinoddini, M (2013). Up-regulation of HOTAIR long non-coding RNA in human gastric adenocarcinoma tissues. Med Oncol 30: 670.
61. Endo, H, Shiroki, T, Nakagawa, T, Yokoyama, M, Tamai, K, Yamanami, H et al. (2013). Enhanced expression of long non-coding RNA HOTAIR is associated with the development of gastric cancer. PLoS ONE 8: e77070.
62. Yang, Z, Zhou, L, Wu, LM, Lai, MC, Xie, HY, Zhang, F et al. (2011). Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Ann Surg Oncol 18: 1243-1250.
63. Kim, K, Jutooru, I, Chadalapaka, G, Johnson, G, Frank, J, Burghardt, R et al. (2013). HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene 32: 1616-1625.
64. He, X, Bao, W, Li, X, Chen, Z, Che, Q, Wang, H et al. (2014). The long non-coding RNA HOTAIR is upregulated in endometrial carcinoma and correlates with poor prognosis. Int J Mol Med 33: 325-332.
65. Ge, XS, Ma, HJ, Zheng, XH, Ruan, HL, Liao, XY, Xue, WQ et al. (2013). HOTAIR, a prognostic factor in esophageal squamous cell carcinoma, inhibits WIF-1 expression and activates Wnt pathway. Cancer Sci 104: 1675-1682.
66. Li, X, Wu, Z, Mei, Q, Li, X, Guo, M, Fu, X et al. (2013). Long non-coding RNA HOTAIR, a driver of malignancy, predicts negative prognosis and exhibits oncogenic activity in oesophageal squamous cell carcinoma. Br J Cancer 109: 2266-2278.
67. Lv, XB, Lian, GY, Wang, HR, Song, E, Yao, H and Wang, MH (2013). Long noncoding RNA HOTAIR is a prognostic marker for esophageal squamous cell carcinoma progression and survival. PLoS ONE 8: e63516.
68. Li, D, Feng, J, Wu, T, Wang, Y, Sun, Y, Ren, J et al. (2013). Long intergenic noncoding RNA HOTAIR is overexpressed and regulates PTEN methylation in laryngeal squamous cell carcinoma. Am J Pathol 182: 64-70.
69. Pasmant, E, Laurendeau, I, Héron, D, Vidaud, M, Vidaud, D and Bièche, I (2007). Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. Cancer Res 67: 3963-3969.
70. Yu, W, Gius, D, Onyango, P, Muldoon-Jacobs, K, Karp, J, Feinberg, AP et al. (2008). Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature 451: 202-206.
71. Prensner, JR, Iyer, MK, Balbin, OA, Dhanasekaran, SM, Cao, Q, Brenner, JC et al. (2011). Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nat Biotechnol 29: 742-749.
72. Xiang, JF, Yin, QF, Chen, T, Zhang, Y, Zhang, XO, Wu, Z et al. (2014). Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus. Cell Res 24: 513-531.
73. Garding, A, Bhattacharya, N, Claus, R, Ruppel, M, Tschuch, C, Filarsky, K et al. (2013). Epigenetic upregulation of lncRNAs at 13q14.3 in leukemia is linked to the In Cis downregulation of a gene cluster that targets NF-kB. PLoS Genet 9: e1003373.
74. Johnsson, P, Ackley, A, Vidarsdottir, L, Lui, WO, Corcoran, M, Grandér, D et al. (2013). A pseudogene long-noncoding-RNA network regulates PTEN transcription and translation in human cells. Nat Struct Mol Biol 20: 440-446.
75. Matouk, IJ, DeGroot, N, Mezan, S, Ayesh, S, Abu-lail, R, Hochberg, A et al. (2007). The H19 non-coding RNA is essential for human tumor growth. PLoS ONE 2: e845.
76. Wang, C, Liu, X, Chen, Z, Huang, H, Jin, Y, Kolokythas, A et al. (2013). Polycomb group protein EZH2-mediated E-cadherin repression promotes metastasis of oral tongue squamous cell carcinoma. Mol Carcinog 52: 229-236.
77. Luo, M, Li, Z, Wang, W, Zeng, Y, Liu, Z and Qiu, J (2013). Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression. Cancer Lett 333: 213-221.
78. Marín-Béjar, O, Marchese, FP, Athie, A, Sánchez, Y, González, J, Segura, V et al. (2013). Pint lincRNA connects the p53 pathway with epigenetic silencing by the Polycomb repressive complex 2. Genome Biol 14: R104.
79. Zhang, EB, Yin, DD, Sun, M, Kong, R, Liu, XH, You, LH et al. (2014). P53-regulated long non-coding RNA TUG1 affects cell proliferation in human non-small cell lung cancer, partly through epigenetically regulating HOXB7 expression. Cell Death Dis 5: e1243.
80. Saayman, S, Ackley, A, Turner, AM, Famiglietti, M, Bosque, A, Clemson, M et al. (2014). An HIV-encoded antisense long noncoding RNA epigenetically regulates viral transcription. Mol Ther 22: 1164-1175.
81. Di Ruscio, A, Ebralidze, AK, Benoukraf, T, Amabile, G, Goff, LA, Terragni, J et al. (2013). DNMT1-interacting RNAs block gene-specific DNA methylation. Nature 503: 371-376.
82. Gordon, T, Castelli, WP, Hjortland, MC, Kannel, WB and Dawber, TR (1977). High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 62: 707-714.
83. Halley, P, Kadakkuzha, BM, Faghihi, MA, Magistri, M, Zeier, Z, Khorkova, O et al. (2014). Regulation of the apolipoprotein gene cluster by a long noncoding RNA. Cell Rep 6: 222-230.
84. Klattenhoff, CA, Scheuermann, JC, Surface, LE, Bradley, RK, Fields, PA, Steinhauser, ML et al. (2013). Braveheart, a long noncoding RNA required for cardiovascular lineage commitment. Cell 152: 570-583.
85. Park, H and Poo, MM (2013). Neurotrophin regulation of neural circuit development and function. Nat Rev Neurosci 14: 7-23.
86. Wang, H, Chan, SA, Ogier, M, Hellard, D, Wang, Q, Smith, C et al. (2006). Dysregulation of brain-derived neurotrophic factor expression and neurosecretory function in Mecp2 null mice. J Neurosci 26: 10911-10915.
87. Fumagalli, F, Racagni, G and Riva, MA (2006). The expanding role of BDNF: a therapeutic target for Alzheimer's disease? Pharmacogenomics J 6: 8-15.
88. Fumagalli, F, Racagni, G and Riva, MA (2006). Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease. Pharmacogenomics J 6: 95-104.
89. Lipovich, L, Dachet, F, Cai, J, Bagla, S, Balan, K, Jia, H et al. (2012). Activity-dependent human brain coding/noncoding gene regulatory networks. Genetics 192: 1133-1148.
90. Velmeshev, D, Magistri, M and Faghihi, MA (2013). Expression of non-protein-coding antisense RNAs in genomic regions related to autism spectrum disorders. Mol Autism 4: 32.
91. Clement, JP, Ozkan, ED, Aceti, M, Miller, CA and Rumbaugh, G (2013). SYNGAP1 links the maturation rate of excitatory synapses to the duration of critical-period synaptic plasticity. J Neurosci 33: 10447-10452.
92. Nagahara, AH and Tuszynski, MH (2011). Potential therapeutic uses of BDNF in neurological and psychiatric disorders. Nat Rev Drug Discov 10: 209-219.
93. Wahlestedt, C (2013). Targeting long non-coding RNA to therapeutically upregulate gene expression. Nat Rev Drug Discov 12: 433-446.
94. DeVos, SL and Miller, TM (2013). Antisense oligonucleotides: treating neurodegeneration at the level of RNA. Neurotherapeutics 10: 486-497.
95. Veedu, RN and Wengel, J (2010). Locked nucleic acids: promising nucleic acid analogs for therapeutic applications. Chem Biodivers 7: 536-542.
96. Longo, FM and Massa, SM (2013). Small-molecule modulation of neurotrophin receptors: a strategy for the treatment of neurological disease. Nat Rev Drug Discov 12: 507-525.
97. Wheeler, TM, Leger, AJ, Pandey, SK, MacLeod, AR, Nakamori, M, Cheng, SH et al. (2012). Targeting nuclear RNA for in vivo correction of myotonic dystrophy. Nature 488: 111-115.
98. Gutschner, T, Hämmerle, M, Eissmann, M, Hsu, J, Kim, Y, Hung, G et al. (2013). The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res 73: 1180-1189.
99. Forbes, DC and Peppas, NA (2012). Oral delivery of small RNA and DNA. J Control Release 162: 438-445.
100. Grillone, LR and Lanz, R (2001). Fomivirsen. Drugs Today 37: 245-255.
101. Wong, E and Goldberg, T (2014). Mipomersen (kynamro): a novel antisense oligonucleotide inhibitor for the management of homozygous familial hypercholesterolemia. P T 39: 119-122.
102. Koo, T and Wood, MJ (2013). Clinical trials using antisense oligonucleotides in duchenne muscular dystrophy. Hum Gene Ther 24: 479-488.
103. Kole, R, Krainer, AR and Altman, S (2012). RNA therapeutics: beyond RNA interference and antisense oligonucleotides. Nat Rev Drug Discov 11: 125-140.
104. Dorsett, Y and Tuschl, T (2004). siRNAs: applications in functional genomics and potential as therapeutics. Nat Rev Drug Discov 3: 318-329.
105. Davidson, BL and McCray, PB Jr (2011). Current prospects for RNA interference-based therapies. Nat Rev Genet 12: 329-340.
106. Biffi, A, Montini, E, Lorioli, L, Cesani, M, Fumagalli, F, Plati, T et al. (2013). Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy. Science 341: 1233158.
107. Aiuti, A, Biasco, L, Scaramuzza, S, Ferrua, F, Cicalese, MP, Baricordi, C et al. (2013). Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome. Science 341: 1233151.
108. Wang, H, Zhang, L and Kung, SK (2010). Emerging applications of lentiviral vectors in dendritic cell-based immunotherapy. Immunotherapy 2: 685-695.
109. DiGiusto, DL, Krishnan, A, Li, L, Li, H, Li, S, Rao, A et al. (2010). RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma. Sci Transl Med 2: 36ra43.
110. Uversky, VN and Dunker, AK (2010). Understanding protein non-folding. Biochim Biophys Acta 1804: 1231-1264.
111. Uversky, VN (2010). The mysterious unfoldome: structureless, underappreciated, yet vital part of any given proteome. J Biomed Biotechnol 2010: 568068.
112. Turoverov, KK, Kuznetsova, IM and Uversky, VN (2010). The protein kingdom extended: ordered and intrinsically disordered proteins, their folding, supramolecular complex formation, and aggregation. Prog Biophys Mol Biol 102: 73-84.
113. Castello, A, Fischer, B, Eichelbaum, K, Horos, R, Beckmann, BM, Strein, C et al. (2012). Insights into RNA biology from an atlas of mammalian mRNA-binding proteins. Cell 149: 1393-1406.
114. Dunker, AK and Uversky, VN (2010). Drugs for 'protein clouds': targeting intrinsically disordered transcription factors. Curr Opin Pharmacol 10: 782-788.
115. Davidovich, C, Zheng, L, Goodrich, KJ and Cech, TR (2013). Promiscuous RNA binding by Polycomb repressive complex 2. Nat Struct Mol Biol 20: 1250-1257.
116. Kaneko, S, Li, G, Son, J, Xu, CF, Margueron, R, Neubert, TA et al. (2010). Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA. Genes Dev 24: 2615-2620.
117. Cifuentes-Rojas, C, Hernandez, AJ, Sarma, K and Lee, JT (2014). Regulatory Interactions between RNA and Polycomb Repressive Complex 2. Mol Cell 55: 171-185.
118. Wu, L, Murat, P, Matak-Vinkovic, D, Murrell, A and Balasubramanian, S (2013). Binding interactions between long noncoding RNA HOTAIR and PRC2 proteins. Biochemistry 52: 9519-9527.
119. McHugh, CA, Russell, P and Guttman, M (2014). Methods for comprehensive experimental identification of RNA-protein interactions. Genome Biol 15: 203.
120. Pang, KC, Frith, MC and Mattick, JS (2006). Rapid evolution of noncoding RNAs: lack of conservation does not mean lack of function. Trends Genet 22: 1-5.
121. Johnsson, P, Lipovich, L, Grandér, D and Morris, KV (2014). Evolutionary conservation of long non-coding RNAs; sequence, structure, function. Biochim Biophys Acta 1840: 1063-1071.
122. Disney, MD, Yildirim, I and Childs-Disney, JL (2014). Methods to enable the design of bioactive small molecules targeting RNA. Org Biomol Chem 12: 1029-1039.
123. Thomas, JR and Hergenrother, PJ (2008). Targeting RNA with small molecules. Chem Rev 108: 1171-1224.
124. Agence franc¸aise de sécurité sanitaire des produits de santé. (2012). Update on good use of injectable aminoglycosides, gentamycin, tobramycin, netilmycin, amikacin. Pharmacological properties, indications, dosage, and mode of administration, treatment monitoring. Med Mal Infect 42: 301-308.
125. Stelzer, AC, Frank, AT, Kratz, JD, Swanson, MD, Gonzalez-Hernandez, MJ, Lee, J et al. (2011). Discovery of selective bioactive small molecules by targeting an RNA dynamic ensemble. Nat Chem Biol 7: 553-559.
126. Kaneko, S, Bonasio, R, Saldaña-Meyer, R, Yoshida, T, Son, J, Nishino, K et al. (2014). Interactions between JARID2 and noncoding RNAs regulate PRC2 recruitment to chromatin. Mol Cell 53: 290-300.
127. Mandal, S, Moudgil, M and Mandal, SK (2009). Rational drug design. Eur J Pharmacol 625: 90-100.
128. Buenrostro, JD, Araya, CL, Chircus, LM, Layton, CJ, Chang, HY, Snyder, MP et al. (2014). Quantitative analysis of RNA-protein interactions on a massively parallel array reveals biophysical and evolutionary landscapes. Nat Biotechnol 32: 562-568.
129. Tome, JM, Ozer, A, Pagano, JM, Gheba, D, Schroth, GP and Lis, JT (2014). Comprehensive analysis of RNA-protein interactions by high-throughput sequencing-RNA affinity profiling. Nat Methods 11: 683-688.
130. Kertesz, M, Wan, Y, Mazor, E, Rinn, JL, Nutter, RC, Chang, HY et al. (2010). Genome-wide measurement of RNA secondary structure in yeast. Nature 467: 103-107.
131. Butter, F, Scheibe, M, Mörl, M and Mann, M (2009). Unbiased RNA-protein interaction screen by quantitative proteomics. Proc Natl Acad Sci USA 106: 10626-10631.
132. Zhang, X, Wu, D, Chen, L, Li, X, Yang, J, Fan, D et al. (2014). RAID: a comprehensive resource for human RNA-associated (RNA-RNA/RNA-protein) interaction. RNA 20: 989-993.
133. Ouyang, Z, Snyder, MP and Chang, HY (2013). SeqFold: genome-scale reconstruction of RNA secondary structure integrating high-throughput sequencing data. Genome Res 23: 377-387.
134. Underwood, JG, Uzilov, AV, Katzman, S, Onodera, CS, Mainzer, JE, Mathews, DH et al. (2010). FragSeq: transcriptome-wide RNA structure probing using high-throughput sequencing. Nat Methods 7: 995-1001.
135. Wan, Y, Qu, K, Zhang, QC, Flynn, RA, Manor, O, Ouyang, Z et al. (2014). Landscape and variation of RNA secondary structure across the human transcriptome. Nature 505: 706-709.
136. Novikova, IV, Hennelly, SP and Sanbonmatsu, KY (2012). Sizing up long non-coding RNAs: do lncRNAs have secondary and tertiary structure? Bioarchitecture 2: 189-199.